Boc-N-alpha-methyl-O-benzyl-L-tyrosine is a protected, non-proteinogenic amino acid derivative. Its structure features an N-terminal tert-butoxycarbonyl (Boc) protecting group, an N-alpha-methyl substitution on the alpha-amino group, and a benzyl (Bn) ether protecting group on the phenolic hydroxyl of the tyrosine side chain. This combination of modifications renders it a specialized building block. This compound is primarily employed in the field of peptide chemistry and medicinal chemistry as a key intermediate for the solid-phase or solution-phase synthesis of modified peptides. The N-methylation enhances the metabolic stability and membrane permeability of the resulting peptides, making it valuable for developing peptide-based therapeutics, such as protease inhibitors or receptor ligands. The Boc and Bn protecting groups are orthogonal and can be selectively removed under standard peptide synthesis conditions. As a non-natural, protected amino acid, it serves as a crucial synthetic precursor for introducing constrained, unnatural structural motifs into peptide backbones. Its use is fundamental in research aimed at improving the pharmacokinetic properties of peptide drugs.